Correlation of electroretinography b-wave absolute latency, plasma levels of human basic fibroblast growth factor, vascular endothelial growth factor, soluble fatty acid synthase, and adrenomedullin in diabetic retinopathy

Journal of Diabetes and its Complications

Volumn 24, Issue 3, 2010, Pages 179-185

  Zakareia, Faten Abdulhady ^a   Alderees, Abdulmageed Abdulrahman ^a   Al Regaiy, Khalid Abdualla ^a   Alrouq, Fawziah Abdallah ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Diabetic retinopathy; Soluble fatty acid synthase; Vascular endothelial growth factor

Indexed keywords

ADRENOMEDULLIN; BASIC FIBROBLAST GROWTH FACTOR; FATTY ACID SYNTHASE; VASCULOTROPIN;

ADULT; APOPTOSIS; ARTICLE; B WAVE; CELL GROWTH; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE DURATION; ELECTRORETINOGRAPHY; ENDOTHELIUM CELL; ENZYME ACTIVITY; EYE EXAMINATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION;

ADRENOMEDULLIN; ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; ELECTRORETINOGRAPHY; FATTY ACID SYNTHETASE COMPLEX; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; MIDDLE AGED; NEOVASCULARIZATION, PHYSIOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 77953132225     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2008.12.007     Document Type: Article

References (30)

1. Aiello L.P., Gardner T.W., King G.L., Blankenship G., Cavallerano J.D., Ferris F.L., and Klein R. Diabetic retinopathy. Diabetes Care 21 (1998) 143-156
2. Alan W., Ciara M., Aine Rice M., David R., Josephine V.G., and Daniel K. Impaired retinal angiogenesis in diabetes (role of advanced glycation end products and galectin-3). Diabetes 54 (2005) 785-794
3. Aristidis V., George L., and King L. Can VEGF reverse diabetic neuropathy in human subjects?. Journal of Clinical Investigations 107 10 (2001) 1215-1218
4. Burtis C.A., and Ashwood E.R. Teitz textbook of clinical chemistry. 2nd ed (1994), WB Saunders Company, Philadelphia 1715
5. Duh E., and Aiello L.P. Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox. Diabetes 48 (1999) 1899-1906
6. Dvorak H.F., Brown L.F., Detmar M., and Dvorak A.M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability and angiogenesis. American Journal of Pathology 146 (1995) 1029-1039
7. Eri S., Hitochi T., Hirokazu O., Kiyoshi S., Izumi S., Hideyasu O.H., and Daisuke W. Leptin stimulates ischemia-induced retinal neovascularization. Diabetes 53 (2004) 2443-2448
8. Err H., Doganay S., Ozerol E., and Yurekli M. Adrenomedullin and leptin levels in diabetic retinopathy and retinal diseases. Ophthalmologica 219 2 (2005) 107-111
9. Garcia M.T., Berrazueta J.R., Montalban C., Amado J.A., and Pesquera C. Plasma adrenomedullin levels in type 1 diabetes. diabetes care 21 6 (1998) 999-1003
10. Grant M.B., Afzal A., Spoerri P., Pan H., Shaw L.C., and Mames R.N. The role of growth factors in the pathogenesis of diabetic retinopathy. Expert Opinion on Investigational Drugs 13 10 (2004) 1275-1293
11. Guillot R., Bringuier A.F., Porokhov B., et al. Increased levels of soluble Fas in serum from diabetic patients with neuropathy. Diabetes and Metabolism 27 (2001) 315-321
12. Harlod Varley M.S.C. Practical clinical biochemistry. 6th ed (1988), Heinemann Medical Books, London 123-155
13. Isner J.M., Ropper A., and Hirst K. VEGF gene transfer for diabetic neuropathy. Human Gene therapy 10 12 12 (2001) 1593-1594
14. Kondo T., Vicent D., Suzuma K., Yanagisawa M., King G.L., and Khan C.R. Knockout of insulin and IGF-1 receptors on vascular endothelial cells protect against retinal neovascularization. Journal of Clinical Investigations 111 (2003) 1835-1842
15. Kowluru R.A. Diabetic retinopathy: mitochondrial dysfunction and retinal capillary cell death. Antioxidants and Redox Signaling 7 11-12 (2005) 1581-1587
16. Layton C.J., Becker S., Neville N., and Osborne. The effect of insulin and glucose levels on retinal glial cell activation and pigment epithelium-derived fibroblast growth factor-2. Molecular Vision 12 (2006) 43-54
17. Masuzawa K., Goto K., Jesmin S., Maeda S., Miyauchi T., Kaji Y., Oshika T., and Hori S. An endothelin type A receptor antagonist reverses upregulated VEGF and ICAM-1 levels in streptozotocin-induced diabetic rat retina. Current Eye Research 31 1 (2006) 79-89
18. Mika N., Hideki K., Keiko N., et al. Effects of basic fibroblast growth factor on experimental diabetic neuropathy in rats. Diabetes 55 (2006) 1470-1477
19. Moriwaki M., Itoh N., and Miyagawa J. Fas and Fas ligand expression in inflamed islets in pancreas sections of patients with recent-onset type I diabetes mellitus. Diabetologia 42 (1999) 1340-1352
20. Nagata S. Apoptosis by death factor. Nature Medicine 88 (1997) 355-365
21. Niu Y.J., Zhao Y.S., Gao Y.X., et al. Therapeutic effect of b-FGF on retina ischemia-reperfusion injury. Chinese Medical Journal 117 (2004) 252-257
22. Okamura T., Ayajiki K., Kangawa K., and Toda N. Mechanism of adrenomedullin induced relaxation in isolated canine retinal arteries. Investigative Ophthalmology and Visual Science 38 (1997) 56-61
23. Pearl-Yafe M., Yolcu E.S., Yaniv I., Stein J., Shirwan H., and Askenasy N. The dual role of Fas-ligand as an injury effector and defense strategy in diabetes and islet transplantation. Bioessays 28 2 (2006) 211-222
24. Serrano J., Alonso D., Fernandez A.F., Encinas J.M., Lopez J.C., and Castro S. ADM in the central nervous system. Microscopy Research and Technique 57 (2002) 76-80
25. Takatoshi S., Itoh H., Chun T., Fukunaga Y., and Yamashita J. Coordinate regulation of endothelin and ADM secretion by oxidative stress in endothelial cells. American Journal of Physiology (Heart and Circulatory Physiology) 281 (2001) H1364-H1371
26. Toyozaki T., Hiroe M., and Saito T. Levels of soluble Fas in patients with myocarditis, heart failure of unknown origin, and in healthy volunteers. American Journal of Cardiology 81 (1998) 798-800
27. Vassiliki P., Antonia M., Nicholas M., Constantine S., Eirini F., and Anthony P. Insulin-like growth factor-I plays a pathogenetic role in diabetic retinopathy. American Journal of Pathology 165 (2004) 457-469
28. Wernig Fand Xu Q. Mechanical stress-induced apoptosis in the cardiovascular system. Progress in Biophysical and Molecular Biology 78 2002 (2002) 105-137
29. Xiao M., Sastry S.M., Li Z.Y., Possin D.E., Chang J.H., Klock I.B., and Milam A.H. Effects of retinal laser photocoagulation on photoreceptor basic fibroblast growth factor and survival. Investigative Ophthalmology and Visual Science 39 (1998) 618-630
30. Zeina D., Yong S., Veronica A., Todd H., Chiara G., and Mara L. Studies of rat and human retinas predict a role for the polyol pathway in human diabetic retinopathy. Diabetes 53 (2004) 2404-2411